Close Menu

NEW YORK (GenomeWeb) – Sigma-Aldrich today reported third quarter revenue growth of 2 percent year over year as it nears the completion of a deal to be acquired by Merck KGaA.

The St. Louis-based research tools and chemicals firm reported total revenues of $703 million for the three months ended Sept. 30, up from $690 million for the third quarter of 2014. On an organic basis, sales were up 9 percent year over year, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.